Status: retired, Primitive. Date: 31-Jul 2018. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 1188446019 | Propranolol hydrochloride+bendrofluazide 160mg/5mg m/r capsule (product) | en | Fully specified name | Inactive | Initial character case insensitive | SNOMED CT core |
| 2153207013 | Propranolol hydrochloride 160mg / bendrofluazide 5mg m/r capsule (product) | en | Fully specified name | Active | Case insensitive | SNOMED CT core |
| 2160838018 | Propranolol hydrochloride 160mg / bendrofluazide 5mg m/r capsule | en | Synonym | Active | Case insensitive | SNOMED CT core |
| 462391015 | Propranolol hydrochloride+bendrofluazide 160mg/5mg m/r capsule | en | Synonym | Inactive | Initial character case insensitive | SNOMED CT core |
| 714785012 | Propranolol hydrochloride+bendrofluazide 160mg/5mg m/r capsule (substance) | en | Fully specified name | Inactive | Initial character case insensitive | SNOMED CT core |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Propranolol hydrochloride 160mg / bendrofluazide 5mg m/r capsule | Is a | Propranolol+diuretic | false | Inferred relationship | Some | ||
| Propranolol hydrochloride 160mg / bendrofluazide 5mg m/r capsule | Has active ingredient | Diuretic | false | Inferred relationship | Some | ||
| Propranolol hydrochloride 160mg / bendrofluazide 5mg m/r capsule | Has active ingredient | Propranolol | false | Inferred relationship | Some | ||
| Propranolol hydrochloride 160mg / bendrofluazide 5mg m/r capsule | Is a | Propranolol hydrochloride + bendrofluazide | false | Inferred relationship | Some | ||
| Propranolol hydrochloride 160mg / bendrofluazide 5mg m/r capsule | Has active ingredient | Propranolol hydrochloride | false | Inferred relationship | Some | ||
| Propranolol hydrochloride 160mg / bendrofluazide 5mg m/r capsule | Has active ingredient | Bendrofluazide - chemical | false | Inferred relationship | Some | ||
| Propranolol hydrochloride 160mg / bendrofluazide 5mg m/r capsule | Has active ingredient | Bendroflumethiazide | false | Inferred relationship | Some | ||
| Propranolol hydrochloride 160mg / bendrofluazide 5mg m/r capsule | Has manufactured dose form | Capsule | false | Inferred relationship | Some | ||
| Propranolol hydrochloride 160mg / bendrofluazide 5mg m/r capsule | Is a | Bendroflumethiazide- and propranolol-containing product | false | Inferred relationship | Some | ||
| Propranolol hydrochloride 160mg / bendrofluazide 5mg m/r capsule | Has manufactured dose form | Conventional release oral capsule | false | Inferred relationship | Some | ||
| Propranolol hydrochloride 160mg / bendrofluazide 5mg m/r capsule | Has manufactured dose form | Modified-release oral capsule | false | Inferred relationship | Some | ||
| Propranolol hydrochloride 160mg / bendrofluazide 5mg m/r capsule | Is a | Propranolol-containing product in oral dose form | false | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
Reference Sets
Concept inactivation indicator reference set
POSSIBLY EQUIVALENT TO association reference set
FHIR